Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission.

[1]  E. Venkatraman,et al.  Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  C. Tournigand,et al.  Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma. , 2001, Gynecologic oncology.

[3]  B N Bundy,et al.  Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Gr , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  T C Randall,et al.  Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings. , 1999, Obstetrics and gynecology.

[5]  E. Venkatraman,et al.  A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with Stage II-IV epithelial ovarian cancer following negative surgical assessment. , 1998, Gynecologic oncology.

[6]  C. Tropé,et al.  Epithelial ovarian carcinoma , 1997, The Lancet.

[7]  D. Alberts,et al.  Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. , 1996, The New England journal of medicine.

[8]  M. Markman.  Intraperitoneal chemotherapy in the treatment of ovarian cancer. , 1996, Annals of medicine.

[9]  F. Parazzini,et al.  Survival of women with advanced ovarian cancer and complete pathologic response at second‐look laparotomy , 1996, Cancer.

[10]  B. Duclos,et al.  Intraperitoneal mitoxantrone as consolidation treatment for patients with ovarian carcinoma in pathologic complete remission , 1994, Cancer.

[11]  M. Jones,et al.  Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative second-look laparotomy. , 1993, Gynecologic Oncology.

[12]  G. Ben-Baruch,et al.  Intraperitoneal cisplatin chemotherapy in ovarian carcinoma patients who are clinically in complete remission. , 1992, Gynecologic oncology.

[13]  C. Perez,et al.  Principles and Practice of Gynecologic Oncology , 1992 .

[14]  A. Sézeur,et al.  Survival with Intraperitoneal Cisplatin in Advanced Ovarian Cancer after Second‐Look Laparotomy , 1992, American journal of clinical oncology.

[15]  C. Louvet,et al.  Sequential cisplatin-doxorubicin, early debulking surgery and intraperitoneal chemotherapy in advanced ovarian cancer. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD). , 1992, European journal of cancer.

[16]  S. Rubin,et al.  Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Lewis,et al.  Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancer. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Howell,et al.  A phase II trial of intraperitoneal cisplatin and etoposide as salvage treatment for minimal residual ovarian carcinoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  L. Marpeau,et al.  Survival after second-look laparotomy in advanced ovarian epithelial cancer. Study of 86 patients. , 1989, European journal of cancer & clinical oncology.

[20]  J. Barrat,et al.  Pronostic des cancers de l'ovaire en fonction des résultats du second look , 1989 .

[21]  L. Marpeau,et al.  [Prognosis in ovarian cancer as a function of the results of the second-look laparatomy]. , 1989, Journal de gynecologie, obstetrique et biologie de la reproduction.

[22]  S. Howell.  Intraperitoneal chemotherapy for ovarian carcinoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Raymond A. Lee,et al.  Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinoma , 1988 .

[24]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .